Concourse Financial Group Securities, Inc. Innate Pharma Sa Transaction History
Concourse Financial Group Securities, Inc.
- $1.56 Billion
- Q2 2024
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding IPHA
# of Institutions
9Shares Held
242KCall Options Held
0Put Options Held
0-
Optiver Holding B.V. Amsterdam, P787.4KShares$193,0470.0% of portfolio
-
Exchange Traded Concepts, LLC86.2KShares$190,5830.0% of portfolio
-
Morgan Stanley New York, NY43.5KShares$96,1880.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il23.5KShares$51,9940.0% of portfolio
-
Barclays PLC London, X0412Shares$9100.0% of portfolio
About Innate Pharma SA
- Ticker IPHA
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 79,893,000
- Market Cap $177M
- Description
- Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and periphera...